Sato Pharmaceutical Inc. recalls WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) an…
- Recall date
- October 1, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0324-2020
- FDA classification
- Class III
- Brand / firm
- Sato Pharmaceutical Inc.
- Sold / distributed
- Nationwide within the United States, Guam and Saipan
Why it was recalled
Subpotent Drug
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,
Get recall alerts
Free email alert whenever Sato Pharmaceutical Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sato Pharmaceutical Inc.